Headache News

SAN DIEGO — Those with migraine who switched from an oral triptan to ubrogepant reported superior outcomes compared with patients who chose another triptan,, according to data presented at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Patients who used two or more triptans for migraine faced more acute treatment, more emergency-related hospital visits and higher medical costs compared with those who used one, data show.

SAN DIEGO — In a small cohort of adults with headache, the most common prodromal symptoms were light and sound sensitivity, fatigue and neck pain, according to research presented at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Treating migraine with a novel formulation of dihydroergotamine powder was linked to favorable outcomes including significant headache pain reduction at 48 hours post dose that was extended to 12 months.

SAN DIEGO —– New daily persistent headache presents itself relatively early in life, is commonly triggered by stress and leads to stigma and disability, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — In a small cohort of young people, use of gepants to treat headache led to some therapeutic benefit and led to few adverse events, according to a poster from the American Headache Society Annual Scientific Meeting.

SAN DIEGO — A wearable remote electrical neuromodulation device provided consistent efficacy and clinically meaningful benefit to those with migraine, according to a poster presentation at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — For younger people with migraine, lidocaine injections were linked to better outcomes compared with saline injections, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Obtaining serum vitamin levels in children with migraine should be part of symptom management, particularly for older adolescents, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Distinctions between burdens faced by those who experience different levels of chronic and episodic migraine should be drawn according to external health care-related factors rather than by symptoms alone, according to a poster.